A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,

Abstract Objective: To compare the short-term efficacy of surfactant administration by laryngeal mask airway versus endotracheal tube. Methods: Preterm infants (28-35 weeks of gestational age), weighing 1 kg or more, with respiratory distress syndrome, requiring nasal continuous positive airway pr...

Full description

Bibliographic Details
Main Authors: Rosilu F. Barbosa, Ana C. Simões e Silva, Yerkes P. Silva
Format: Article
Language:English
Published: Elsevier
Series:Jornal de Pediatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572017000400343&lng=en&tlng=en
_version_ 1811217839169732608
author Rosilu F. Barbosa
Ana C. Simões e Silva
Yerkes P. Silva
author_facet Rosilu F. Barbosa
Ana C. Simões e Silva
Yerkes P. Silva
author_sort Rosilu F. Barbosa
collection DOAJ
description Abstract Objective: To compare the short-term efficacy of surfactant administration by laryngeal mask airway versus endotracheal tube. Methods: Preterm infants (28-35 weeks of gestational age), weighing 1 kg or more, with respiratory distress syndrome, requiring nasal continuous positive airway pressure, with increased respiratory effort and/or fraction of inspired oxygen (FiO2) ≥ 0.40 to maintain oxygen saturation 91-95%, were randomized to receive surfactant by LMA following nCPAP or by ETT following mechanical ventilation (MV). The primary outcome was a clinical response defined as FiO2 ≤ 0.30 three hours after surfactant. Secondary outcomes for LMA group were: need of surfactant retreatment during the first 24 h, MV requirement, and presence of surfactant in gastric content. Results: Forty-eight patients were randomized; 26 in the LMA group and 22 in the ETT group. Six of 26 patients (23%) in the LMA group and five of 22 patients (22.7%) in the ETT group did not meet the primary outcome (p = 0.977). Fourteen (53.8%) of the LMA patients were not intubated nor ventilated; 12 (46.1%) were ventilated: for surfactant failure (23%), for nCPAP failure (11.5%), and for late complications (11.5%). Groups were similar regarding prenatal status, birth conditions, and adverse events. No significant gastric content was found in 61.5% of the LMA patients. Oxygen and second dose surfactant requirements, arterial/alveolar ratio, and morbidities were similar among groups. Conclusions: Surfactant administration by LMA showed short-term efficacy, with similar supplementary oxygen need compared to surfactant by ETT, and lower MV requirement. Further studies with larger sample size are necessary to confirm these results.
first_indexed 2024-04-12T07:01:23Z
format Article
id doaj.art-d5aaa001d4134e65bd3edc5c1f5ae3da
institution Directory Open Access Journal
issn 1678-4782
language English
last_indexed 2024-04-12T07:01:23Z
publisher Elsevier
record_format Article
series Jornal de Pediatria
spelling doaj.art-d5aaa001d4134e65bd3edc5c1f5ae3da2022-12-22T03:43:00ZengElsevierJornal de Pediatria1678-478293434335010.1016/j.jped.2016.08.007S0021-75572017000400343A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,Rosilu F. BarbosaAna C. Simões e SilvaYerkes P. SilvaAbstract Objective: To compare the short-term efficacy of surfactant administration by laryngeal mask airway versus endotracheal tube. Methods: Preterm infants (28-35 weeks of gestational age), weighing 1 kg or more, with respiratory distress syndrome, requiring nasal continuous positive airway pressure, with increased respiratory effort and/or fraction of inspired oxygen (FiO2) ≥ 0.40 to maintain oxygen saturation 91-95%, were randomized to receive surfactant by LMA following nCPAP or by ETT following mechanical ventilation (MV). The primary outcome was a clinical response defined as FiO2 ≤ 0.30 three hours after surfactant. Secondary outcomes for LMA group were: need of surfactant retreatment during the first 24 h, MV requirement, and presence of surfactant in gastric content. Results: Forty-eight patients were randomized; 26 in the LMA group and 22 in the ETT group. Six of 26 patients (23%) in the LMA group and five of 22 patients (22.7%) in the ETT group did not meet the primary outcome (p = 0.977). Fourteen (53.8%) of the LMA patients were not intubated nor ventilated; 12 (46.1%) were ventilated: for surfactant failure (23%), for nCPAP failure (11.5%), and for late complications (11.5%). Groups were similar regarding prenatal status, birth conditions, and adverse events. No significant gastric content was found in 61.5% of the LMA patients. Oxygen and second dose surfactant requirements, arterial/alveolar ratio, and morbidities were similar among groups. Conclusions: Surfactant administration by LMA showed short-term efficacy, with similar supplementary oxygen need compared to surfactant by ETT, and lower MV requirement. Further studies with larger sample size are necessary to confirm these results.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572017000400343&lng=en&tlng=enLaryngeal mask airwayPreterm infantPulmonary surfactant
spellingShingle Rosilu F. Barbosa
Ana C. Simões e Silva
Yerkes P. Silva
A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,
Jornal de Pediatria
Laryngeal mask airway
Preterm infant
Pulmonary surfactant
title A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,
title_full A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,
title_fullStr A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,
title_full_unstemmed A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,
title_short A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates,
title_sort randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates
topic Laryngeal mask airway
Preterm infant
Pulmonary surfactant
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572017000400343&lng=en&tlng=en
work_keys_str_mv AT rosilufbarbosa arandomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates
AT anacsimoesesilva arandomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates
AT yerkespsilva arandomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates
AT rosilufbarbosa randomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates
AT anacsimoesesilva randomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates
AT yerkespsilva randomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates